Cepheid
Nicolas Brouchon currently serves as the VP of Finance at Cepheid, overseeing a $1.2 billion revenue operation across Europe, Africa, and the Middle East, managing risk mitigation, compliance, and development projects. Previous experience includes a tenure as VP of Finance at Checkpoint Systems Inc., where leadership extended to finance operations across 50 countries and building shared service centers. Earlier roles at SLB included positions as Shared Services Manager, Controller for various divisions, and Field Controller, focusing on harmonizing accounting processes and decentralizing operations. Nicolas Brouchon holds a Master's degree from IPAG Business School and has additional education from Science Po and Villanova University.
This person is not in any offices
Cepheid
9 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.